Maple Syrup Urine Disease
"Maple Syrup Urine Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An autosomal recessive inherited disorder with multiple forms of phenotypic expression, caused by a defect in the oxidative decarboxylation of branched-chain amino acids (AMINO ACIDS, BRANCHED-CHAIN). These metabolites accumulate in body fluids and render a "maple syrup" odor. The disease is divided into classic, intermediate, intermittent, and thiamine responsive subtypes. The classic form presents in the first week of life with ketoacidosis, hypoglycemia, emesis, neonatal seizures, and hypertonia. The intermediate and intermittent forms present in childhood or later with acute episodes of ataxia and vomiting. (From Adams et al., Principles of Neurology, 6th ed, p936)
Descriptor ID |
D008375
|
MeSH Number(s) |
C10.228.140.163.100.520 C16.320.565.100.608 C16.320.565.189.520 C18.452.132.100.520 C18.452.648.100.608 C18.452.648.189.520
|
Concept/Terms |
Maple Syrup Urine Disease- Maple Syrup Urine Disease
- Keto Acid Decarboxylase Deficiency
- Branched-Chain alpha-Keto Acid Dehydrogenase Deficiency
- Branched Chain alpha Keto Acid Dehydrogenase Deficiency
- Branched-Chain Ketoaciduria
- Branched Chain Ketoaciduria
- Branched-Chain Ketoacidurias
- Ketoaciduria, Branched-Chain
- Ketoacidurias, Branched-Chain
- MSUD (Maple Syrup Urine Disease)
Classic Maple Syrup Urine Disease- Classic Maple Syrup Urine Disease
- Maple Syrup Urine Disease, Classic
- Maple Syrup Urine Disease, Classical
- Classical Maple Syrup Urine Disease
|
Below are MeSH descriptors whose meaning is more general than "Maple Syrup Urine Disease".
- Diseases [C]
- Nervous System Diseases [C10]
- Central Nervous System Diseases [C10.228]
- Brain Diseases [C10.228.140]
- Brain Diseases, Metabolic [C10.228.140.163]
- Brain Diseases, Metabolic, Inborn [C10.228.140.163.100]
- Maple Syrup Urine Disease [C10.228.140.163.100.520]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Metabolism, Inborn Errors [C16.320.565]
- Amino Acid Metabolism, Inborn Errors [C16.320.565.100]
- Maple Syrup Urine Disease [C16.320.565.100.608]
- Brain Diseases, Metabolic, Inborn [C16.320.565.189]
- Maple Syrup Urine Disease [C16.320.565.189.520]
- Nutritional and Metabolic Diseases [C18]
- Metabolic Diseases [C18.452]
- Brain Diseases, Metabolic [C18.452.132]
- Brain Diseases, Metabolic, Inborn [C18.452.132.100]
- Maple Syrup Urine Disease [C18.452.132.100.520]
- Metabolism, Inborn Errors [C18.452.648]
- Amino Acid Metabolism, Inborn Errors [C18.452.648.100]
- Maple Syrup Urine Disease [C18.452.648.100.608]
- Brain Diseases, Metabolic, Inborn [C18.452.648.189]
- Maple Syrup Urine Disease [C18.452.648.189.520]
Below are MeSH descriptors whose meaning is more specific than "Maple Syrup Urine Disease".
This graph shows the total number of publications written about "Maple Syrup Urine Disease" by people in this website by year, and whether "Maple Syrup Urine Disease" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 0 | 1 | 1 | 2003 | 1 | 0 | 1 | 2010 | 1 | 0 | 1 | 2018 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Maple Syrup Urine Disease" by people in Profiles.
-
Schenck D, Mazariegos GV, Thistlethwaite JR, Ross LF. Ethical Analysis and Policy Recommendations Regarding Domino Liver Transplantation. Transplantation. 2018 05; 102(5):803-808.
-
Walsh KS, Scott MN. Neurocognitive profile in a case of maple syrup urine disease. Clin Neuropsychol. 2010 May; 24(4):689-700.
-
Ross LF. An ethical and policy analysis of elective transplantation for metabolic conditions diagnosed by newborn screening. J Pediatr. 2010 Jan; 156(1):139-44.
-
Gupta B, Waggoner D. Ophthalmoplegia in maple syrup urine disease. J AAPOS. 2003 Aug; 7(4):300-2.
-
Waisbren SE, Read CY, Ampola M, Brewster TG, Demmer L, Greenstein R, Ingham CL, Korson M, Msall M, Pueschel S, Seashore M, Shih VE, Levy HL. Newborn screening compared to clinical identification of biochemical genetic disorders. J Inherit Metab Dis. 2002 Nov; 25(7):599-600.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|